Stock Events

Stock Events

Essa Pharma 

C$0.2
37
-C$0-1.85% Wednesday 20:00

Statistics

Day High
0.21
Day Low
0.19
52W High
5.97
52W Low
0.18
Volume
5,822,895
Avg. Volume
7,572,938
Mkt Cap
0
P/E Ratio
-
Dividend Yield
1,164.11%
Dividend
2.34

Upcoming

21
AUG
Dividend Payment
Estimated
 
25
AUG
Dividend Ex
Estimated
 
20
AUG 27
Dividend Payment
Estimated
 
25
AUG 27
Dividend Ex
Estimated
 

Dividends

1,164.11%Dividend Yield
Aug 25
C$2.34
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

23DecExpected
Q1 2024
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.25
-0.19
-0.14
-0.09
Expected EPS
-0.16
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-28.54MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow EPIX. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Puma Biotechnology
PBYI
Mkt Cap256.89M
Puma Biotechnology is involved in the development of cancer therapeutics, competing in the same space as Essa Pharma.
Array Technologies
ARRY
Mkt Cap1.32B
Array BioPharma focuses on the discovery, development, and commercialization of targeted small molecule drugs to treat cancer.
Incyte
INCY
Mkt Cap18.35B
Incyte Corporation operates in the development of oncology products, directly competing with Essa Pharma's cancer-focused therapies.
Exelixis
EXEL
Mkt Cap10.41B
Exelixis, Inc. is a biotechnology company that develops small molecule therapies for the treatment of cancer, competing in the oncology sector.

About

ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreements with Caris Life Sciences, Inc.; Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.
Show more...
CEO
Mr. David S. Wood C.M.A., CPA, CMA, CPA, M.B.A., MBA
Employees
35
Country
CA

Listings

0 Comments

Share your thoughts

FAQ

What is Essa Pharma stock price today?▼
The current price of EPIX is C$0.2 CAD — it has decreased by -1.85% in the past 24 hours. Watch Essa Pharma stock price performance more closely on the chart.
What is Essa Pharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Essa Pharma stocks are traded under the ticker EPIX.
Is Essa Pharma stock price growing?▼
EPIX stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Essa Pharma has showed a -87.1% decrease.
What is Essa Pharma revenue for the last year?▼
Essa Pharma revenue for the last year amounts to 0 CAD.
What is Essa Pharma net income for the last year?▼
EPIX net income for the last year is -28.54M CAD.
Does Essa Pharma pay dividends?▼
Yes, EPIX dividends are paid en. The last dividend per share was 2.34 CAD. As of today, Dividend Yield (FWD)% is 1,164.11%.
How many employees does Essa Pharma have?▼
As of April 01, 2026, the company has 35 employees.
In which sector is Essa Pharma located?▼
Essa Pharma operates in the Health Care sector.
When did Essa Pharma complete a stock split?▼
The last stock split for Essa Pharma was on April 25, 2018 with a ratio of 1:20.
Where is Essa Pharma headquartered?▼
Essa Pharma is headquartered in Vancouver, CA.